Vertex Pharmaceuticals Inc $92.01

down -3.55


30/7/2014 04:00 PM  |  NASDAQ : VRTX  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get VRTX Trend Analysis - it has outperformed the S&P 500 by 3%

Partner Headlines

  1. Vertex Is Poised For An Earnings Breakout

    Benzinga
  2. Merck, Gilead Lead Race To Eradicate Hepatitis C

    IBD
  3. Analyst Concerns On Vertex's Approved Drug

    Benzinga
  4. Benzinga's Top Downgrades

    Benzinga
  5. Vertex Soars On Drug Study

    IBD
  6. Utility Sector Rises; Elizabeth Arden Shares Slide Over 3.6%

    Benzinga
  7. Micron Gains On Upbeat Earnings; Elizabeth Arden Shares Slide

    Benzinga
  8. Nasdaq Hits 14-Year High; Facebook Breaks Out

    IBD
  9. Deutsche Bank Reiterates Buy on Vertex Pharmaceuticals Following Press ...

    Benzinga
  10. Vertex Cystic Fibrosis Success Quells Street's Doubts

    IBD
  11. Bernstein Weighs In On Vertex Move

    Benzinga
  12. Benzinga's Volume Movers

    Benzinga
  13. Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Misses ...

    Benzinga
  14. Stocks Hitting 52-Week Highs

    Benzinga
  15. Morning Market Movers

    Benzinga
  16. Stocks Poised For Soft Start; Vertex Rockets In Premarket

    IBD
  17. Why Are Vertex Pharmaceuticals Up More Than 50 Percent?

    Benzinga
  18. Benzinga's Top #PreMarket Gainers

    Benzinga
  19. Indexes End With Small Gains; Tesla Drives Higher

    IBD
  20. Vertex Shares Hit Hard On Trial Concerns

    Benzinga
  21. Benzinga's Top #PreMarket Losers

    Benzinga
  22. Health Care Sector in an Upward Climb in June

    GuruFocus
  23. For The Record

    IBD
  24. Vertex Pharmaceuticals

    IBD
  25. Nasdaq Up 1.7%; Bed, Bath & Beyond Sinks After Hours

    IBD
  26. House Probe Of Gilead's Sovaldi Price Hits Biotechs

    IBD
  27. Gilead Pricing Probed By House; Biotech Stocks Drop

    IBD
  28. Dow, S&P 500 Up, Nasdaq Slips; Drugmakers Falling Hard

    IBD
  29. BioMed Realty Trust Leases Space To Life Science Firms

    IBD
  30. Stocks Open Higher, Turn Mixed After Employement Report

    IBD
  31. Revenue Growth: Focus On Healthcare Stocks

    YCharts
  32. Enanta Joins Big Leagues With Hepatitis C Drug

    IBD
  33. Vertex drug trial results mixed

    IBD
  34. Vertex Cystic Fibrosis Trial Has Good, Bad News

    IBD
  35. Benzinga's Top #PreMarket Losers

    Benzinga
  36. Vertex Pharma Says Phase 3 Study Results of Ivacaftor Did Not Meet Primary ...

    Benzinga
  37. Trade Idea of the Day: Short Vertex

    Benzinga
  38. Nasdaq Leads Stocks Higher; Archer Daniels Deal Blocked

    IBD
  39. US Stock Futures Edge Lower Ahead Of FOMC Minutes, Economic Data

    Benzinga
  40. Vertex Sells INCIVO Product Royalty Rights to Janssen Pharmaceutica for ...

    Benzinga
  41. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    Benzinga
  42. Vertex Drug, Fastest Blockbuster, Quickly Fading

    YCharts
  43. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, ...

    Benzinga
  44. Vertex Announces Oral Selective JAK3 Inhibitor VX-509 Shows Statistically ...

    Benzinga
  45. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  46. J&J Buys Glaxo Drug In Hunt For All-Oral HCV Therapy

    IBD
  47. Stocks Post Broad, Soft Losses; Amgen, Vertex Drag On Nasdaq

    IBD
  48. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)

    Benzinga
  49. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, ...

    Benzinga
  50. Big Contingent Of Industries Outpace Nasdaq Rebound

    IBD
Trading Center